Test Code CA125 Cancer Antigen 125
Additional Codes
| Hospital Ordering Code |
|---|
| LAB155 CA125 |
Specimen Requirements
Container/Tube Type:
Green No Gel (Lithium Heparin)
Light Green (Lithium Heparin Plasma Separator Tube)
Red (No Additive)
SST (Serum Separator)
Preferred Collection Container:
Green No Gel (Lithium Heparin)
Light Green (Lithium Heparin Plasma Separator Tube)
Also Acceptable Collection Container:
Plasma from Lavender tubes is acceptable but will not route in the Laboratory Information System (Sunquest).
Transport Information:
1 mL serum, frozen.
Minimum Sample Volume:
0.5 mL
Remarks:
Separate serum from cells ASAP. Avoid repeated freeze/thaw cycles. CA 125 II assay testing is not recommended as a screening procedure to diagnose cancer in the general population.
Stability
Refrigerated Stability:
7 days
Frozen Stability:
6 months (Avoid repeated freeze/thaw cycles)
Performing Laboratory
Pathology Laboratory, UnityPoint Health, Des Moines
CPT
86304
Methodology
Electrochemiluminescence
Interpretive Data:
The testing method is an electrochemiluminescence assay manufactured by Roche Diagnostics Inc. and performed on the Cobas system. Values obtained with different assay methods or kits may be different and cannot be used interchangeably.
Performance
Sun-Sat
Analytical Time:
Same day
Testing Laboratory:
Pathology Laboratory
Laboratory Section:
Core Laboratory
Alias
CA125 (Cancer Antigen 125), Cancer Antigen 125, Carbohydrate Antigen 125, OV Monitor, Ovarian Cancer-Related Antibodies, Cancer Ag 125 (CA 125), Serum